These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8597126)

  • 1. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis.
    Lake BG
    Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.
    Lake BG
    Annu Rev Pharmacol Toxicol; 1995; 35():483-507. PubMed ID: 7598504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferators: their biological and toxicological effects.
    Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
    Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic peroxisome proliferation in rodents and its significance for humans.
    Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
    Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
    Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of rodent liver carcinogenesis.
    Michalopoulos GK; Eckl PM; Cruise JL; Novicki DL; Jirtle RL
    Toxicol Ind Health; 1987 Jun; 3(2):119-28. PubMed ID: 3303445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
    Cattley RC; DeLuca J; Elcombe C; Fenner-Crisp P; Lake BG; Marsman DS; Pastoor TA; Popp JA; Robinson DE; Schwetz B; Tugwood J; Wahli W
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):47-60. PubMed ID: 9629596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
    Reddy JK; Rao MS
    Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
    Chevalier S; Roberts RA
    Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
    Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
    Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
    Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK
    Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peroxisome proliferation and possible cancer hazard].
    Dybing E; Sanner T
    Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
    Lake BG; Evans JG; Cunninghame ME; Price RJ
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
    Tomaszewski KE; Agarwal DK; Melnick RL
    Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS; Cattley RC; Conway JG; Popp JA
    Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
    Reddy JK; Lalwai ND
    Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
    Marsman DS; Goldsworthy TL; Popp JA
    Carcinogenesis; 1992 Jun; 13(6):1011-7. PubMed ID: 1600604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.